Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUPILUMAB vs ECALLANTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUPILUMAB vs ECALLANTIDE: Safety Overview

Metric DUPILUMAB ECALLANTIDE
Total FAERS Reports 379,249 1,206
Deaths Reported 1,536 23
Death Rate 0.4% 1.9%
Hospitalizations 17,008 499
Average Patient Age 44.7 yrs 42.9 yrs
% Female Patients 61.2% 84.1%
Manufacturer sanofi-aventis U.S. LLC Takeda Pharmaceuticals America, Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Prescription